{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:00:44Z","timestamp":1774288844823,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bulcan.2015.11.009","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T16:46:58Z","timestamp":1453913218000},"page":"299-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Les leuc\u00e9mies aigu\u00ebs de l\u2019enfant de moins d\u2019un an\u00a0: des maladies rares, encore un d\u00e9fi"],"prefix":"10.1016","volume":"103","author":[{"given":"Beno\u00eet","family":"Brethon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Cav\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mony","family":"Fahd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2015.11.009_bib0240","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/363358a0","article-title":"In utero rearrangements in the trithorax-related oncogene in infant leukemias","volume":"363","author":"Ford","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0245","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1073\/pnas.94.25.13950","article-title":"Backtracking leukemia to birth: identifiation of clonotypic gene fusion sequences in neonatal spots","volume":"94","author":"Gale","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0250","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1073\/pnas.95.8.4584","article-title":"Fetal origins of TEL-AML1\u00a0fusion gene in identical twins with leukemia","volume":"95","author":"Ford","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0255","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(99)09403-9","article-title":"Prenatal origin of acute lymphoblastique leukaemia in children","volume":"354","author":"Wiemels","year":"1999","journal-title":"The Lancet"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood.V89.1.281","article-title":"Monoclonal origin of concordant T-cell malignancy in identical twins","volume":"89","author":"Ford","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0265","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.1073\/pnas.112218799","article-title":"Chromosome translocations and covert leukemic clones are generated during fetal development","volume":"99","author":"Mori","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0270","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0275","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1139851","article-title":"Modeling the initiation and progression of human acute leukemia in mice","volume":"316","author":"Barab\u00e9","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0280","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"St. Jude Children's Research Hospital \u2013 Washington University Pediatric Cancer Genome Project. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0285","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.V96.1.24","article-title":"Biological and therapeutic aspects of infant leukemia","volume":"96","author":"Biondi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0290","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","article-title":"Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23\u00a0chromosomal region","volume":"359","author":"Pui","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0295","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2285::AID-CNCR10>3.0.CO;2-Q","article-title":"Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium","volume":"80","author":"Silverman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0300","first-page":"534","article-title":"Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies","volume":"91","author":"Biondi","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0305","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia","volume":"94","author":"D\u00f6rdelmann","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0310","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2141.1994.tb04727.x","article-title":"Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group","volume":"86","author":"Ferster","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0315","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1182\/blood-2005-07-3011","article-title":"Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953\u00a0from the Children's Oncology Group","volume":"108","author":"Hilden","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0320","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1200\/JCO.1999.17.2.445","article-title":"Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group","volume":"17","author":"Reaman","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0325","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-2141.2002.03442.x","article-title":"Medical Research Council working party on childhood leukaemia. Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987\u20131999","volume":"117","author":"Chessells","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0330","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00043426-199701000-00005","article-title":"Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493)","volume":"19","author":"Frankel","year":"1997","journal-title":"J Pediatr Hematol oncol"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0335","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00043426-199805000-00008","article-title":"Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: a Pediatric Oncology Group Pilot Study","volume":"20","author":"Lauer","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0340","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1\u00a0year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0345","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1046\/j.1365-2141.2002.03754.x","article-title":"Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia study (MLL96)","volume":"118","author":"Isoyama","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0350","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood-2005-11-4728","article-title":"Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results of the Japan Infant Leukemia Study Group","volume":"107","author":"Nagayama","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0355","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2010-03-273532","article-title":"Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99\u00a0study","volume":"116","author":"Mann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0360","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/leu.2009.17","article-title":"Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99\u00a0protocol","volume":"23","author":"Van der Velden","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0365","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","author":"Meyer","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0370","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1172\/JCI116978","article-title":"Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes","volume":"93","author":"Sorensen","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0375","first-page":"1625","article-title":"ALL-1\u00a0gene rearrangements in acute myeloid leukemia: association with M4\u2013M5\u00a0French-American-British classification subtypes and young age","volume":"55","author":"Cimino","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0380","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/1042819031000063363","article-title":"Recent advances in the treatment of infant acute myeloid leukemia","volume":"44","author":"Ishii","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0385","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood.V98.13.3589","article-title":"Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group","volume":"98","author":"Kawasaki","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0390","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0165-4608(91)90213-E","article-title":"Non-random t(1;22)(p12\u201313;q13) in acute megakaryocytic malignant proliferation","volume":"54","author":"Baruchel","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0395","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.V78.3.748.748","article-title":"The t(1;22) (p13;q13) is non-random and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study","volume":"78","author":"Carroll","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0400","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V79.12.3325.bloodjournal79123325","article-title":"The translocation t(1;22) (p13;q13) is a non-random marker specifically associated with acute megakaryocytic leukemia in young children","volume":"79","author":"Lion","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0405","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sj.leu.2401639","article-title":"Nineteen cases of the t(1;22) (p13;q13) acute megakaryoblastic leukaemia of infants\/children and a review of 39\u00a0cases: report from a t(1;22) study group","volume":"14","author":"Bernstein","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0410","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1073\/pnas.101001498","article-title":"Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia","volume":"98","author":"Mercher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0415","first-page":"608","article-title":"Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: children's cancer group studies 2861and 2891","volume":"91","author":"Lange","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0420","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1046\/j.1365-2141.2003.04229.x","article-title":"Transient leukemia: a benign form of leukaemia in newborn infants with trisomy\u00a021","volume":"120","author":"Zipursky","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0425","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1182\/blood-2003-01-0013","article-title":"GATA1\u00a0mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome","volume":"101","author":"Hitzler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0430","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0929-693X(96)81281-4","article-title":"Neonatal acute leukemia: a propos of 7\u00a0cases","volume":"2","author":"Cumin","year":"1995","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0435","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00043426-200305000-00002","article-title":"Fetal and neonatal leukemia","volume":"25","author":"Isaacs","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0440","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1182\/blood-2009-02-204214","article-title":"Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99\u00a0protocol","volume":"114","author":"Van der Linden","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0445","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/2040620714565963","article-title":"Novel agents for the treatment of childhood acute leukemia","volume":"6","author":"Annesley","year":"2015","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0450","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/leu.2011.278","article-title":"Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia","volume":"26","author":"Stumpel","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0455","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","article-title":"Potent inhibition of DOT1L as treatment of MLL-fusion leukemia","volume":"122","author":"Daigle","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0460","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1200\/JCO.2014.55.3628","article-title":"Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase\u00a0III children's oncology group trial\u00a0AAML0531","volume":"32","author":"Gamis","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0465","series-title":"2014th congress of the American Society of Hematology","article-title":"Gemtuzumab Ozogamicin (GO) in infants with Acute Myeloid Leukemia (AML) \u2013 combined results from the Children's Oncology Group (COG) Trials AAML03P1\u00a0and AAML0531","author":"Guest","year":"2015"},{"key":"10.1016\/j.bulcan.2015.11.009_bib0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2015.02.033","article-title":"Clinical overview of anti-CD19\u00a0BiTE\u00ae and ex vivo data from anti-CD33\u00a0BiTE\u00ae as examples for retargeting T\u00a0cells in hematologic malignancies","author":"Zugmaier","year":"2015","journal-title":"Mol Immunol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115003690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115003690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T12:52:28Z","timestamp":1600087948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115003690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0007455115003690"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.11.009","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les leuc\u00e9mies aigu\u00ebs de l\u2019enfant de moins d\u2019un an\u00a0: des maladies rares, encore un d\u00e9fi","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}